Paula Krause

Recommended Articles

• Managing Symptomatic Endometriosis

  Endometriosis is known as a disease that affects women through their reproductive age. It is the most common cause of chronic pelvic pain,  usually beginning in adolescence. It is also one of the main causes of infertility among women. It is a complex condition with a great variability when it...

• What Is the GOLO Diet

  The GOLO diet is meant to help a person maintain their insulin levels to lose weight and increase their metabolic rate. Because of a higher metabolic rate, it also helps them increase their energy levels. Although, this diet does not work for everybody. To see if this diet works for you, here is an...

• A True Calling: Two-Time Cancer Survivor Sets Her Sights on Nursing

  Although she has only been a nurse for a short time, Michelle McGovern’s life experience with cancer have given her a unique backbone for bedside care.  There were only two things Michelle McGovern needed to do—just two little things.The first was she write a book to let her son and daughter...

• What is Acral Lentiginous Melanoma?

  Acral lentiginous melanoma is a type of melanoma arising on the palms or soles of the feet. Acral lentiginous melanoma is not just a fancy name for melanoma on the fingers, toes, palm, soles of the feet, and under the nails, but it is also a type of melanoma that is the rarest among melanomas,...

• Everything Parents Should Know Before Treating Heat Rash

  Heat rash, which is also called as "miliaria" or "prickly heat" is a condition that affects the skin mostly out of a blockage of the sweat ducts. The blockage of these sweat pores is mostly known to be as a result of excess sweating, which leaves the pores unable to excrete all the sweat. Upon...

• FDA Approves Orkambi to Treat Young Children with Cystic Fibrosis

  Orkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...